Top Research Reports for Meta Platforms, Broadcom & JPMorgan

03.06.25 18:00 Uhr

Werte in diesem Artikel
Aktien

228,45 EUR -3,50 EUR -1,51%

597,80 EUR -3,30 EUR -0,55%

Indizes

PKT PKT

42.265,6 PKT -162,2 PKT -0,38%

21.696,3 PKT -25,6 PKT -0,12%

16.827,6 PKT -39,6 PKT -0,23%

2.911,2 PKT -7,8 PKT -0,27%

5.954,2 PKT -16,6 PKT -0,28%

Tuesday, June 3, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Broadcom Inc. (AVGO) and JPMorgan Chase & Co. (JPM). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>Ahead of Wall StreetThe daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens and attempts to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.You can read today's AWS here >>> Pre-Markets Slightly Lower Ahead of Open; JOLTS, Earnings to ComeToday's Featured Research ReportsMeta Platforms’ shares have outperformed the Zacks Internet - Software industry over the past year (+41.2% vs. +38.4%). The company is benefiting from steady user growth across all regions, particularly Asia-Pacific. Increased engagement for its offerings like Instagram, WhatsApp, Messenger and Facebook has been a major growth driver. META has been leveraging AI to improve the potency of its platform offerings. These services currently reach more than 3.43 billion people daily. Meta Platforms’ growing footprint among young adults, driven by improving recommendations, boosts its competitive prowess. AI usage is making it a popular name among advertisers. This is expected to drive top-line growth. Meta Platforms now expects to invest significantly more over the next few years in developing more advanced models and the largest AI services in the world. However, monetization of these AI services will take considerable time, which may be a concern.(You can read the full research report on Meta Platforms here >>>)Shares of Broadcom have outperformed the Zacks Electronics - Semiconductors industry over the past year (+88.5% vs. +26.4%). The company is benefiting from strong demand for its networking products and custom AI accelerators (XPUs), as witnessed in first-quarter fiscal 2025. Strong demand for Broadcom’s application-specific integrated chips (ASICs), designed to support AI and machine learning, aids top-line growth. Broadcom expects second-quarter fiscal 2025 AI revenues to jump 44% year over year to $4.4 billion. The acquisition of VMware has benefited Infrastructure software solutions. As of fiscal first quarter, roughly 70% of Broadcom’s largest 10,000 customers have adopted VMware Cloud Foundation. Broadcom’s expanding AI portfolio, along with a rich partner base, reflects solid top-line growth potential. However, gross margin in its fiscal Q2 is expected to contract sequentially on unfavorable revenue and product mix. High debt levels are a headwind.(You can read the full research report on Broadcom here >>>)JPMorgan’s shares have outperformed the Zacks Financial - Investment Bank industry over the past year (+36.1% vs. +31.4%). The company’s first-quarter 2025 results reflected solid capital markets performance and loan demand. Business expansion efforts, decent loan demand and high rates support net interest income (NII). The Zacks analyst expects NII (managed) to show a CAGR of 2.4% by 2027. While a solid resurgence in deal-making activities is likely to take time, a solid pipeline will drive the investment banking (IB) business. We expect IB fees to witness a CAGR of 2.2% by 2027. Yet, the volatile nature of the capital markets business and high mortgage rates will hurt fee income growth. Our estimate for the metric shows a 6.2% fall in 2025. As it invests in technology and marketing, expenses are expected to remain high. Our estimates for non-interest expenses imply a CAGR of 2.4% by 2027. Weak asset quality is a concern.(You can read the full research report on JPMorgan here >>>)Other noteworthy reports we are featuring today include Carvana Co. (CVNA), Agnico Eagle Mines Ltd. (AEM) and Entergy Corp. (ETR).Mark VickerySenior EditorNote: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>Today's Must ReadExpanding AI Usage Drives Meta Platforms' (META) ProspectsStrong Demand for Networking Products Aids Broadcom (AVGO)Buyouts, High Rates Aid JPMorgan (JPM) Amid Fee Income WoesFeatured ReportsGrowth Projects, Kirkland Buyout Aid Agnico Eagle (AEM)Per the Zacks analyst, the company will benefit from investment in growth projects to expand output. The Kirkland Gold acquisition has also provided an extensive pipeline of exploration projects.Investments Aid Entergy Corporation (ETR) Amid Poor SolvencyPer the Zacks analyst, Entergy Corporation makes disciplined investment to maintain and upgrade the reliability of its electric utility systems.Arch Capital (ACGL) Poised to Grow on Solid Premium GrowthPer the Zacks analyst, Arch Capital is set to grow on solid Insurance and Reinsurance business driving improvement in premiums. However, exposure to cat loss inducing underwriting volatility concerns.Western Midstream (WES) Banks on Long-Term Expansion ProjectPer the Zacks analyst, Western Midstream is expanding on long-term infrastructure projects, though high costs and falling gas volumes raise concerns.Strength in Public Spending Aids KBR's Growth, High Costs AilPer the Zacks analyst, KBR is gaining from strong secular growth trends across diverse sectors and its asset-light model. However, ongoing macro risks and inflated costs are marring prospects.Glaukos' (GKOS) Strong Glaucoma Franchise Offset CompetitionPer the Zacks analyst, Glaukos' key franchise, Glaucoma, along with Corneal Health continue on their growth trend due to strong demand which is likely help the company fight off stiff competition.National Vision (EYE) Banks on Top Cohorts, Rivalry GrowsThe Zacks analyst is impressed with the ongoing momentum in National Vision's three target customer cohorts' managed care, progressive, and outside Rx customers. Yet, fierce rivalry may hurt growth.New UpgradesGrowth in Retail Unit Sales & EBITDA Aid Carvana (CVNA)Per the Zacks analyst, an expected increase in year-over-year growth of retail unit sales is likely to boost Carvana's top line. Its focus on driving adjusted EBITDA per unit also bodes well.InterDigital (IDCC) Rides on Solid Licensing Momentum, AI FocusPer the Zacks analyst, healthy licensing momentum in the smartphone business combined with a strong focus on AI innovation for wireless and video technology will likely boost InterDigital top line.Amarin (AMRN) Rides on Robust Vascepa Sales Performance in EUPer the Zacks analyst, label expansion of Amarin's sole marketed drug, Vascepa, in European markets is driving the top line. The recent restructuring plan to streamline operations also holds promise.New DowngradesAmicus' (FOLD) High Dependence on Galafold for Revenues a WoePer the Zacks analyst, Amicus remains heavily dependent on lead drug, Galafold, for revenue, which is a concern. Any regulatory setback for the drug will weigh heavily on the stock.Delta Air Lines (DAL) Continues to Grapple With Rising ExpensesThe Zacks Analyst is worried about the fact that increased labor and airport costs does not bode well for Southwest Airlines' bottom line.Molson Coors (TAP) Q1 Volumes Drop Sharply Amid DemandPer the Zacks analyst, Molson Coors' volumes sank as macro headwinds, weak demand, and lost contracts hit key regions hard. In first quarter of 2025, Americas volume fell 15.6%, EMEA&APAC fell 9.7%.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report JPMorgan Chase & Co. (JPM): Free Stock Analysis Report Entergy Corporation (ETR): Free Stock Analysis Report Agnico Eagle Mines Limited (AEM): Free Stock Analysis Report Broadcom Inc. (AVGO): Free Stock Analysis Report Carvana Co. (CVNA): Free Stock Analysis Report Meta Platforms, Inc. (META): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: JPMorgan Chase und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Broadcom

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Broadcom

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Meta Platforms (ex Facebook)

Wer­bung

Analysen zu Meta Platforms (ex Facebook)

DatumRatingAnalyst
04.06.2025Meta Platforms (ex Facebook) OverweightJP Morgan Chase & Co.
06.05.2025Meta Platforms (ex Facebook) KaufenDZ BANK
01.05.2025Meta Platforms (ex Facebook) OverweightJP Morgan Chase & Co.
01.05.2025Meta Platforms (ex Facebook) BuyJefferies & Company Inc.
01.05.2025Meta Platforms (ex Facebook) OutperformRBC Capital Markets
DatumRatingAnalyst
04.06.2025Meta Platforms (ex Facebook) OverweightJP Morgan Chase & Co.
06.05.2025Meta Platforms (ex Facebook) KaufenDZ BANK
01.05.2025Meta Platforms (ex Facebook) OverweightJP Morgan Chase & Co.
01.05.2025Meta Platforms (ex Facebook) BuyJefferies & Company Inc.
01.05.2025Meta Platforms (ex Facebook) OutperformRBC Capital Markets
DatumRatingAnalyst
02.02.2023Meta Platforms (ex Facebook) HaltenDZ BANK
27.10.2022Meta Platforms (ex Facebook) NeutralJP Morgan Chase & Co.
28.07.2022Meta Platforms (ex Facebook) NeutralJP Morgan Chase & Co.
21.07.2022Meta Platforms (ex Facebook) NeutralJP Morgan Chase & Co.
29.06.2022Meta Platforms (ex Facebook) NeutralJP Morgan Chase & Co.
DatumRatingAnalyst
12.05.2022Meta Platforms (ex Facebook) HoldHSBC
05.12.2019Facebook ReduceHSBC
31.01.2019Facebook SellPivotal Research Group
31.10.2018Facebook SellPivotal Research Group
12.10.2018Facebook SellPivotal Research Group

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Meta Platforms (ex Facebook) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen